Rates, Risks and Routes to Reduce Vascular Dementia (R4VaD)
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-044
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
PendingResearch Location
United KingdomLead Research Institution
UK Dementia Research InstituteResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Subject
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Individuals with multimorbidityOther
Occupations of Interest
Unspecified
Abstract
Amendment to an existing UK-wide observational study of stroke and its cognitive and neuropsychiatric complications R4VaD, (as a high risk population for vascular dementia) to collect data on the impact of COVID-19 on stroke patients with vascular disease. These patients have higher risk of catching and having severe COVID disease, are often on ACE inhibitors which may affect their risk. Neurological complications have been reported in a third of COVID-19 infected patients, and patients already in R4VaD follow-up are reporting high levels of anxiety. All ethics, HRA and NRS approvals are in place; recruitment has commenced where resource is available.